While psilocybin is a controlled Schedule I substance, the FDA is allowing the University of Texas Health Science Center at Houston to test it as part of a global Phase II clinical trial.

The post University In Houston Testing Psilocybin For Treatment-Resistant Depression appeared first on High Times.

Continue reading…

Trending stories from over 100 sources, YouTube and Twitter
Our archive contains 41,877 news items. 315 articles added this week.